New leadership for Bayer as Ashraf Al-Ouf secures promotion to Asia Pacific role

October 18, 2023 Latest News BioPharma BioPharmaDispatch Executive

This is a preview of subscriber content

Subscribe now to continue reading.

Bayer has announced that Ashraf Al-Ouf, CEO of the Bayer Group in Australia and New Zealand and general manager of Pharmaceuticals, has been appointed head of commercial operations of pharmaceuticals in the Asia Pacific. …

Subscribe now to continue reading.

New leadership for Bayer as Ashraf Al-Ouf secures promotion to Asia Pacific role

This is a preview of subscriber content

Latest Video

Most Read

HTA reform is fine, but why is the underpinning framework immutable?

Olympian joins call urging vigilance on meningococcal risk

Patient Voice Initiative announces the appointment of new president

The need to correct a profound misconception of what ethical decision-making is and is not

New Australian collaboration to build gene and cell therapy production

New Stories

NDIS keeps growing but signs emerge that reforms are starting to work

USTR launches new investigation, with minimal ambition on pharmaceuticals

New Zealand starting to benefit after lifting advertising prohibition

Mark Butler restates support for health technology assessment reform

Brandon BioCatalyst welcomes the inclusion of its CUREator in new program

Cancer Australia launches research program targeting early-onset cancers

Imugene completes significant placement and launches share purchase plan

Sign In

New leadership for Bayer as Ashraf Al-Ouf secures promotion to Asia Pacific role

This is a preview of subscriber content

Latest Video

Most Read

HTA reform is fine, but why is the underpinning framework immutable?

Olympian joins call urging vigilance on meningococcal risk

Patient Voice Initiative announces the appointment of new president

The need to correct a profound misconception of what ethical decision-making is and is not

New Australian collaboration to build gene and cell therapy production

Follow Us

New Stories

NDIS keeps growing but signs emerge that reforms are starting to work

USTR launches new investigation, with minimal ambition on pharmaceuticals

New Zealand starting to benefit after lifting advertising prohibition

Mark Butler restates support for health technology assessment reform

Brandon BioCatalyst welcomes the inclusion of its CUREator in new program

Cancer Australia launches research program targeting early-onset cancers

Imugene completes significant placement and launches share purchase plan